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Bladder tumors are commonly seen urologic tumors.
The most common type of bladder tumor is urothe-
lial carcinoma [1]. According to WHO classification,
urothelial tumors are divided into two major catego-
ries: infiltrating urothelial carcinoma and noninvasive
urothelial neoplasias. The second category consists 
of carcinoma in situ, noninvasive papillary urothelial
carcinoma, urothelial papilloma and inverted urothelial
papilloma [2]. Inverted papilloma (IP) is an uncommon
tumor of the urinary tract, accounting for about 2.2%
of tumors of the urinary system [3]. IPs are charac-
terized by a proliferating urothelium arranged as
inverted cords and nests with an intact overlying
urothelium [4]. The clinical features are not specific
and urothelial carcinoma shares similar endoscopic
and radiologic appearances with IP [3,4]. IP of the
urinary tract usually occurs as a solitary lesion, but
3.6–6.0% appear to be multicentric [5]. In general, IP
is considered to be a benign lesion. The benign clini-
cal course of IP is based on its histologic appearance,
low incidence of multiple tumors, low rate of local
recurrence (1–7%), and lack of invasive growth and
metastasis [3–5]. Although IP is traditionally regarded
as a benign tumor, conflicting data on its multiplicity,
recurrence rates and association with urothelial carci-
noma have left uncertainties concerning its biologic
behavior [6,7].
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Inverted papilloma (IP) of the urothelium accounts for 2.2% of urothelial neoplasms. The aim of
this study was to report the results of 13 patients with urinary IP, pointing out the clinical features,
presentations, treatment options and outcomes. The mean age and mean follow-up periods of the
patients were 60.23 ± 3.25 (range, 44–81) years and 30 (range, 6–42) months, respectively. There
was no coexistence of urothelial carcinoma with IP at presentation. Cystoscopy showed a solitary
papillary tumor in the bladders of 11 patients and solid pedunculated tumors in the remaining
two patients. The site of development was the bladder in 12 cases (92%) and ureter in one (8%)
case. Transurethral bladder tumor resection was performed in 12 cases. For the case with IP in the
ureter, nephroureterectomy was performed. Pathologic examination demonstrated that seven of
the 13 cases were of the trabecular type and six were of the glandular type. Of the 13 cases, two
(7%) had recurrence, at 1 year and 1 month and 1 year and 5 months from initial resection. The
male to female ratio was 5.5:1. Initial symptoms included macroscopic hematuria in five cases,
microscopic hematuria in four, and dysuria and microscopic hematuria in three; one case was
asymptomatic. IPs of the urinary bladder are benign tumors that can be treated successfully by
transurethral resection and fulguration of the tumor bed. In addition, these lesions must be 
followed up closely for recurrence and malignant transformation.
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In this study, we evaluated 13 cases with IP of the
lower urinary tract, along with the relevant literature.
PATIENTS AND METHODS
From 1990 to 2004, 13 patients with urothelial IP of
the lower urinary tract were treated in our clinic. The
evaluations covered personal data, history, symptoms,
localization of the disease, recurrences, and malignant
transformations. All patients were evaluated preop-
eratively by physical examination, urinary ultrasonog-
raphy (US), urinalysis, hematologic and biochemical
analyses, and cystoscopy. None of the patients had 
a history of previous bladder tumor. Histopathologic
diagnosis was made according to the criteria of
Henderson et al [8]. In 1975, Henderson et al sug-
gested the following histologic characteristics for
making a diagnosis of IP of the urinary tract: (1)
inverted configuration, similar to an IP of the upper
respiratory tract; (2) normal urothelial lining; (3) uni-
formity of urothelial cells; (4) microcyst crypt forma-
tion; (5) absent or infrequent mitosis; and (6) squamous
metaplasia. Follow-up consisted of cystoscopy, urinary
ultrasonography and ureteroscopy every 3 months.
RESULTS
The mean age of the patients was 60.23 ± 3.25 (range,
44–81) years. The mean follow-up period was 30
(range, 6–42) months. Of the 13 patients, 11 were men
and two were women. Physical findings were unre-
markable in all patients. The site of development was
the bladder in 12 cases (92%) and the ureter in one
(8%). Of the 12 bladder tumors, three (25%) were in
the trigone, six (50%) were on the left lateral wall, one
(8.3%) was on the posterior wall, and two (16.7%)
were on the right lateral wall (Table). In nine patients,
an excretory urogram (IVP) was performed. A filling
defect was seen in three (33.3%) cases, unrelated
changes, such as stones, were seen in one (11.1%),
and a normal IVP was seen in five (55.6%). An IVP
demonstrated a left proximal ureteral filling defect
causing a grade 3–4 left-sided hydroureteronephrosis
in one patient. Initial symptoms included macro-
scopic hematuria in five cases, microscopic hema-
turia in four, and dysuria and microscopic hematuria
in three; one case was asymptomatic. There was no
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coexistence of urothelial carcinoma with IP at pre-
sentation. Cystoscopy showed a papillary tumor in
the bladder in 11 patients and solid pedunculated
tumors in the remaining two. Transurethral bladder
tumor resection was performed in 12 cases. Nephro-
ureterectomy was performed on the case with IP in
the ureter. Eleven patients were followed up for 2.5
years without any evidence of recurrence. However,
of the 13 cases, two (7%) had recurrences; the times to
recurrence from initial resection were 1 year 1 month
and 1 year 5 months, and both recurrences occurred
in the bladder. Cystoscopy revealed sessile papillary
tumors on the left lateral wall and trigone of the uri-
nary bladder in these two patients. Pathologic diag-
noses was urothelial carcinoma (Grade 1, stage Ta)
and IP. Pathologic examination by hematoxylin and
eosin staining demonstrated that seven of the 13
cases were of the trabecular type and six were of the
glandular type. The typical histologic appearances of
IPs are shown in the Figure.
DISCUSSION
IP was first described by Paschkis [9] in 1927 as a 
distinctive, polypoid inverted epithelial structure
located in the bladder; then it was clinically named
by Potts and Hirst in 1963 [10]. Other names, such as
adenourothelioma and Brunnian adenoma, were also
used to describe the same lesion. The development 
of IP in the urinary tract has been reported in about
1,000 cases since it was reported by Potts and Hirst 
in 1963 [4]. Inverted urothelial papillomas are more
common in males than females. This unusually high
male preponderance is out of line with other bladder
tumors, since urothelial carcinoma has only a 2:1 male
predominance [11]. In our series, the male-to-female
ratio was 5.5:1 (11 vs. 2). In different series, the male-
to-female ratio ranges from 3:1 to 7:1 [12]. Although
these lesions are usually single, they may be seen as
bilateral lesions in the ureter or as multiple IPs. Our
data confirm these findings. An IP of the urinary tract
Urinary inverted papillomas
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Figure. (A) Cellular cords separated by loose stroma and microcyst formation under the epithelium (hematoxylin & eosin [H&E],
100×). (B) Inverted papilloma showing smooth urothelial epithelium and cellular inverted anastomosing urothelial islands underneath
(H&E, 100×). (C) Inverted papilloma with a smooth urothelial surface and underlying urothelial cords (H&E, 100×). (D) Inverted
papilloma with normal overlying urothelium and microcysts containing umbrella cells (H&E, 200×).
is usually seen in the 5th or 6th decade of life, but it
may occur at any age, and some cases in children
have been reported [13]. The mean age of the patients
in our study was 60.23 years. The majority (80–90%)
of IP cases occur in the bladder, and nearly 80% of IP
cases in the bladder are found in the neck or triangle
region, while IPs of the upper urinary tract and pro-
static urethra are very rare [14]. Among our cases,
92.3% developed in the bladder, consistent with pre-
vious reports. In the literature, the reported incidence
of IP ranges between 1.6% and 4.5% [15,16]. During the
period of the present study, the number of operations
for urinary tumor in our clinic was 319 and the inci-
dence of IP was 4.07%, similar to the levels reported
by other investigators [3,12].
The clinical significance of this entity remains con-
troversial. Until the 1970s, urinary IP had generally
been regarded as a benign tumor in the epithelium 
of the urinary tract, centering on the bladder. How-
ever, in the 1980s, several reported cases suggested
the malignant potential of IP, including those with
evidence of malignancy, those showing recurrences
and those with recurrence of urothelial carcinoma [4].
Thus, the association of IPs of the bladder and urothe-
lial carcinoma has been well documented, but the
incidence is low. In contrast, IPs of the upper urothe-
lial tract frequently coexist with urothelial malignan-
cies [17]. Spevack et al have maintained that the
association between IPs and urinary epithelial malig-
nant tumors is more pronounced in the upper uri-
nary tract and reported that seven out of 30 cases of
upper urinary tract IP were complicated with urothe-
lial carcinoma [18]. Finally, these authors pointed out
two major problems in the clinical management of
this disease: the tendency to recur (7–41.4%) [4,19] and
the potential for malignant transformation (1–10.34%)
into urothelial carcinoma [7,19]. In our study, the recur-
rence rate was similar to those in previous studies
[7–19].
The etiology of IP is not yet clearly understood. 
In their first description of this lesion, Potts and Hirst
suggested that an IP is a neoplastic transformation of
basal cells of subcervical Albarran’s or subtrigonal
Home’s glands [10]. Because IPs were later found out-
side the bladder, this idea seemed very unlikely [20].
Instead, Trites stated that this lesion was an inverted
variant of urothelial papilloma, a belief adopted by
some others [21]. A high frequency in the trigone and
bladder neck and localization of the IP in the pelvis
and ureter may be explained by the mesodermal origin
of the urothelium of these areas, whereas the remain-
der of the bladder epithelium is derived from endo-
derm. In contrast to this view, Cummings [22] and
Matz et al [23] postulated that this lesion was not
neoplastic, but rather a kind of hyperplastic reaction,
especially of Brunn’s cell nests, to chronic inflamma-
tion or irritative agents. This could explain the pre-
dominance in areas of greatest irritative potential, the
rare multicentricity and the very low recurrence rate
of IP. In recent years, this theory has been supported
by others. Several reports stress the importance of
inflammatory causative factors because of the associ-
ation with cystitis glandularis and hyperplasia of
Von Brunn’s nests, and, for this reason, IP can also be
called Brunnerioma [4,21,23]. Today, most authors
believe that IP of the urinary tract is a true neoplasm,
although the precise tissue of origin and the causative
agents or processes are still not known.
The typical gross appearance has been character-
ized as nonpapillary, noninvasive, smooth-surfaced,
and pedunculated or sessile polypoid lesions of the
urothelium [12,14,20]. Despite their exophytic gross
appearance, IPs are histologically characterized by
an endophytic growth of anatomizing cords and rib-
bons of mature urothelial cells into a fibrovascular
stroma. Microscopically, the polypoid structure is
covered with thin urothelium that often invaginates
in nests, some of which may have a cystic appearance
[7]. IPs have been noted to resemble papillary cysti-
tis, von Brunn’s nests, cystitis cystica and cystitis
glandularis. Although the early descriptions of IP
emphasized the lack of stromal inflammation, mitotic
activity or cell atypia, subsequent reports describe
examples with these features [18,20]. IPs range in size
from a few millimeters to 3–4 cm in their greatest
dimension, but most are smaller than 3 cm, as in our
cases.
Preoperative diagnosis of IP is difficult. There are
no specific radiologic characteristics to support the
diagnosis of IP. Usually, a filling defect or signs of
obstruction are seen on contrast films. However, these
findings are not specific [4,7]. In our series, the most
frequent abnormalities on IVPs were filling defects
(33.3%, vs. 54.9% in the literature). Some authors
have reported the diagnosis of lesions by ultrasound.
Because IPs are covered by a normal and intact mucosal
layer, the cytologic morphology falls within the range
of normal or degenerate transitional epithelium, as
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can be seen in patients with stones and a variety of
inflammatory conditions.
With regard to bladder tumors, endoscopy, direct
visualization and biopsy are the most frequent diag-
nostic procedures used to detect IPs [7,14,22,24].
Henderson et al defined six criteria for the diagnosis
of IP [8]. However, it can still be difficult to differenti-
ate this lesion from low-grade urothelial carcinoma,
cystitis cystica, cystitis glandularis and Brunn’s cell
nests [8,17]. In IPs, the tumor surface is generally
intact, smooth and dome-shaped, and the ramifying
cords are of even width. However, the surface of an
IP-like urothelial carcinoma is sometimes exophytic
and variable, and the ramifying cords and trabeculae
have irregular widths, which are not characteristic
features of IPs. Cell atypia, nuclear pleomorphism,
irregularities of chromatin distribution and an appre-
ciable mitotic rate are the prominent features in the
diagnosis of urothelial cell carcinomas [4,21]. The coex-
istence of urothelial carcinoma and IP is well docu-
mented, especially in the bladder. However, in our
study, there was no coexistence of urothelial carcinoma
at presentation.
The associated clinical symptoms do not differ
greatly from other urothelial neoplasms. Renal colic
is the most common clinical manifestation of upper
urinary tract lesions. There are no clinical criteria 
to differentiate IP from urothelial carcinoma. Even 
if hematurias and radiologic filling defects can be
explored by ureterescopy, it is impossible to conclude
that a tumor is an IP [11,17]. Approximately the same
results were obtained from our cases. These tumors
usually present with painless hematuria, dysuria or
bladder outlet obstruction, but they can be asympto-
matic as demonstrated in one of our cases. Among
our cases, five (38.5%) had gross hematuria, while
dysuria was found in three (23.1%). Today, we do not
know of any reliable parameter that allows for the
identification of patients with an increased risk of
recurrence or malignant transformation. Some authors
have suggested that human papillomavirus may play
a role in the pathogenesis of IP [25,26]. Determination
of DNA ploidy and the proliferative index may be
useful for the appropriate management of this disease.
Regarding IP in the upper urinary tract, various
surgical procedures, such as total nephroureterectomy
with bladder cuff, partial resection of the ureter and
endoscopic surgery, are used [7,20,24]. A patient with
ureteral IP was treated with nephroureterectomy and
cuff resection in the present study. In fact, resection
under an endoscope or partial resection of the ureter
would be sufficient if an IP could be positively diag-
nosed before or during surgery. The use of frozen 
section microscopy during operation for selected
tumors of the upper urinary tract may facilitate local-
ized resection. However, frozen sections may be diffi-
cult to interpret. Lausten and associates noted that IP
may easily be mistaken for an invasive carcinoma 
on frozen section analysis because of the pattern of
growth and the difficulty of evaluating the absence 
of cellular atypia [24]. Because of initial diagnostic
problems, many patients are treated with open sur-
gery. Simple transurethral resection of the tumor and/
or electrocoagulation is generally accepted as the
treatment of choice for IPs in the bladder [7,20]. In
our series, all patients with IPs in the bladder were
treated with transurethral resection.
Some authors do not advocate frequent and long-
term follow-up because of the histologic appearance,
rare multiplicity, very low recurrence rate and absence
of progression [27–29]. In contrast, most authors agree
that patients with IP must be considered to be at risk
for recurrence and treatment should be followed up
with endoscopy and radiographic studies for recur-
rence [30]. Witjes et al concluded that IP was not 
a risk factor for urothelial carcinoma of the urinary
tract, and frequent and long-term follow-up was not
needed if the histologic diagnosis was definitive [12].
They had a single case of subsequent urothelial carci-
noma development and two of IP recurrence. In con-
trast, Cheng et al have advocated regular cystoscopy
despite finding a single case of subsequent urothelial
cell carcinoma nearly 4 years after the initial diagno-
sis of IP, with no IP recurrence [31]. Such published
results provide practicing urologists with conflicting
information. In conclusion, IPs of the urinary bladder
are benign tumors that can be treated successfully by
transurethral resection and fulguration of the tumor
bed. In addition, these lesions must be followed up
closely for recurrence and malignant transformation.
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